| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Embolization, Therapeutic | 24 | 2025 | 279 | 6.780 |
Why?
|
| Radiography, Interventional | 28 | 2025 | 154 | 3.940 |
Why?
|
| Arteriovenous Malformations | 5 | 2025 | 50 | 3.890 |
Why?
|
| Pulmonary Veins | 5 | 2025 | 96 | 3.770 |
Why?
|
| Radiology, Interventional | 14 | 2022 | 66 | 3.380 |
Why?
|
| Vena Cava Filters | 16 | 2022 | 90 | 3.030 |
Why?
|
| Arteriovenous Fistula | 6 | 2023 | 54 | 2.840 |
Why?
|
| Renal Dialysis | 26 | 2024 | 364 | 2.660 |
Why?
|
| Catheterization, Central Venous | 21 | 2015 | 120 | 2.560 |
Why?
|
| Graft Occlusion, Vascular | 17 | 2024 | 100 | 2.530 |
Why?
|
| Catheterization | 19 | 2023 | 238 | 2.530 |
Why?
|
| Gastrostomy | 9 | 2023 | 69 | 2.520 |
Why?
|
| Catheters, Indwelling | 23 | 2014 | 113 | 2.330 |
Why?
|
| Pulmonary Embolism | 13 | 2022 | 235 | 2.180 |
Why?
|
| Gastrointestinal Hemorrhage | 14 | 2024 | 246 | 2.170 |
Why?
|
| Pulmonary Artery | 5 | 2025 | 341 | 1.990 |
Why?
|
| Vena Cava, Inferior | 13 | 2022 | 143 | 1.840 |
Why?
|
| Venous Thrombosis | 11 | 2021 | 257 | 1.640 |
Why?
|
| Arteriovenous Shunt, Surgical | 14 | 2024 | 76 | 1.610 |
Why?
|
| Carcinoma, Hepatocellular | 7 | 2022 | 426 | 1.540 |
Why?
|
| Liability, Legal | 3 | 2022 | 29 | 1.490 |
Why?
|
| Device Removal | 13 | 2022 | 166 | 1.470 |
Why?
|
| Malpractice | 4 | 2022 | 57 | 1.380 |
Why?
|
| Liver Neoplasms | 8 | 2022 | 793 | 1.380 |
Why?
|
| Stents | 19 | 2014 | 422 | 1.350 |
Why?
|
| Computed Tomography Angiography | 5 | 2025 | 166 | 1.290 |
Why?
|
| Angiography | 9 | 2022 | 209 | 1.260 |
Why?
|
| Humans | 161 | 2025 | 96108 | 1.170 |
Why?
|
| Catheters | 4 | 2023 | 90 | 1.120 |
Why?
|
| Angioplasty, Balloon | 12 | 2006 | 98 | 1.100 |
Why?
|
| Chemoembolization, Therapeutic | 3 | 2020 | 32 | 1.080 |
Why?
|
| Treatment Outcome | 41 | 2025 | 9175 | 1.060 |
Why?
|
| Postoperative Complications | 15 | 2020 | 2592 | 1.010 |
Why?
|
| Portal Vein | 9 | 2013 | 122 | 0.990 |
Why?
|
| Endoleak | 3 | 2017 | 42 | 0.970 |
Why?
|
| Kidney Failure, Chronic | 8 | 2024 | 432 | 0.930 |
Why?
|
| Retrospective Studies | 47 | 2024 | 10287 | 0.890 |
Why?
|
| Catheterization, Peripheral | 6 | 2021 | 64 | 0.880 |
Why?
|
| Brachiocephalic Veins | 6 | 2020 | 33 | 0.870 |
Why?
|
| Jugular Veins | 12 | 2007 | 73 | 0.830 |
Why?
|
| Liver Transplantation | 13 | 2013 | 1201 | 0.830 |
Why?
|
| Colonic Diseases | 4 | 2015 | 61 | 0.820 |
Why?
|
| Telangiectasia, Hereditary Hemorrhagic | 1 | 2023 | 15 | 0.820 |
Why?
|
| Middle Aged | 64 | 2025 | 28369 | 0.810 |
Why?
|
| Male | 84 | 2025 | 45865 | 0.790 |
Why?
|
| Superior Vena Cava Syndrome | 1 | 2023 | 16 | 0.780 |
Why?
|
| Surgical Stomas | 1 | 2023 | 22 | 0.770 |
Why?
|
| Cardiac Tamponade | 1 | 2023 | 23 | 0.770 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2023 | 108 | 0.750 |
Why?
|
| Time Factors | 24 | 2025 | 5580 | 0.730 |
Why?
|
| Female | 82 | 2025 | 50030 | 0.720 |
Why?
|
| Blood Vessel Prosthesis | 5 | 2013 | 248 | 0.710 |
Why?
|
| Carbon Dioxide | 1 | 2022 | 212 | 0.710 |
Why?
|
| Aneurysm, False | 2 | 2013 | 55 | 0.700 |
Why?
|
| Angiography, Digital Subtraction | 5 | 2024 | 100 | 0.670 |
Why?
|
| Aged | 49 | 2024 | 20968 | 0.650 |
Why?
|
| Tomography, X-Ray Computed | 14 | 2022 | 2777 | 0.640 |
Why?
|
| Radiology Department, Hospital | 2 | 2020 | 24 | 0.630 |
Why?
|
| Thrombosis | 8 | 2024 | 326 | 0.620 |
Why?
|
| Aortic Aneurysm, Abdominal | 4 | 2017 | 121 | 0.610 |
Why?
|
| Adult | 44 | 2025 | 28722 | 0.610 |
Why?
|
| Prosthesis Failure | 3 | 2014 | 125 | 0.610 |
Why?
|
| Contrast Media | 10 | 2022 | 1096 | 0.610 |
Why?
|
| Peripheral Vascular Diseases | 3 | 2009 | 62 | 0.600 |
Why?
|
| Subclavian Vein | 5 | 2003 | 16 | 0.590 |
Why?
|
| Radiologists | 1 | 2019 | 54 | 0.590 |
Why?
|
| Phlebography | 8 | 2017 | 67 | 0.540 |
Why?
|
| Vascular Surgical Procedures | 3 | 2022 | 152 | 0.540 |
Why?
|
| Vascular Patency | 11 | 2024 | 127 | 0.540 |
Why?
|
| Aneurysm | 2 | 2022 | 61 | 0.510 |
Why?
|
| Mesenteric Arteries | 2 | 2015 | 29 | 0.510 |
Why?
|
| Renal Artery | 2 | 2023 | 46 | 0.510 |
Why?
|
| Radiology | 3 | 2015 | 206 | 0.510 |
Why?
|
| Appendicitis | 4 | 2001 | 66 | 0.500 |
Why?
|
| Hemostatics | 3 | 2013 | 61 | 0.500 |
Why?
|
| Diagnostic Imaging | 6 | 2019 | 475 | 0.490 |
Why?
|
| Kidney Transplantation | 1 | 2023 | 882 | 0.490 |
Why?
|
| Blood Vessel Prosthesis Implantation | 6 | 2024 | 239 | 0.480 |
Why?
|
| Thrombolytic Therapy | 7 | 2020 | 261 | 0.480 |
Why?
|
| Aged, 80 and over | 21 | 2024 | 7229 | 0.480 |
Why?
|
| Aortic Aneurysm | 2 | 2013 | 82 | 0.470 |
Why?
|
| Ultrasonography | 7 | 2014 | 747 | 0.470 |
Why?
|
| Catheter Ablation | 3 | 2022 | 266 | 0.470 |
Why?
|
| Thrombectomy | 3 | 2020 | 220 | 0.460 |
Why?
|
| Angioplasty | 6 | 2014 | 69 | 0.460 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 346 | 0.450 |
Why?
|
| Physicians | 1 | 2022 | 707 | 0.450 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 334 | 0.450 |
Why?
|
| Constriction, Pathologic | 14 | 2014 | 219 | 0.450 |
Why?
|
| Hepatic Artery | 2 | 2013 | 84 | 0.420 |
Why?
|
| Young Adult | 11 | 2025 | 7026 | 0.420 |
Why?
|
| Pandemics | 1 | 2020 | 880 | 0.420 |
Why?
|
| Adolescent | 23 | 2025 | 9896 | 0.410 |
Why?
|
| Recurrence | 7 | 2024 | 1219 | 0.410 |
Why?
|
| Risk Factors | 15 | 2025 | 5961 | 0.410 |
Why?
|
| Upper Extremity | 1 | 2014 | 65 | 0.410 |
Why?
|
| Salvage Therapy | 1 | 2014 | 238 | 0.400 |
Why?
|
| Schools, Medical | 1 | 2014 | 144 | 0.400 |
Why?
|
| Thrombin | 1 | 2013 | 61 | 0.390 |
Why?
|
| Patient-Centered Care | 1 | 2015 | 228 | 0.390 |
Why?
|
| Mesenteric Veins | 1 | 2013 | 36 | 0.390 |
Why?
|
| Abdominal Injuries | 1 | 2013 | 52 | 0.390 |
Why?
|
| Bile Duct Neoplasms | 2 | 2024 | 91 | 0.380 |
Why?
|
| Cone-Beam Computed Tomography | 2 | 2025 | 73 | 0.370 |
Why?
|
| Vascular Diseases | 3 | 2002 | 123 | 0.370 |
Why?
|
| Risk Assessment | 8 | 2025 | 2480 | 0.370 |
Why?
|
| Endovascular Procedures | 2 | 2013 | 334 | 0.370 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2013 | 118 | 0.360 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2012 | 61 | 0.350 |
Why?
|
| Hospitals, University | 1 | 2012 | 199 | 0.350 |
Why?
|
| Hospital Costs | 1 | 2012 | 117 | 0.340 |
Why?
|
| Radiography | 9 | 2013 | 826 | 0.340 |
Why?
|
| Evidence-Based Medicine | 3 | 2012 | 458 | 0.330 |
Why?
|
| Cholecystectomy | 2 | 2008 | 26 | 0.330 |
Why?
|
| Veins | 6 | 2006 | 94 | 0.330 |
Why?
|
| Thorax | 3 | 2023 | 80 | 0.330 |
Why?
|
| Predictive Value of Tests | 5 | 2025 | 1805 | 0.320 |
Why?
|
| Radiography, Thoracic | 2 | 2011 | 334 | 0.320 |
Why?
|
| Anticoagulants | 5 | 2020 | 463 | 0.320 |
Why?
|
| Rupture | 5 | 2023 | 62 | 0.310 |
Why?
|
| Prosthesis Design | 5 | 2019 | 310 | 0.310 |
Why?
|
| Hand Injuries | 1 | 2009 | 16 | 0.310 |
Why?
|
| Cumulative Trauma Disorders | 1 | 2009 | 19 | 0.300 |
Why?
|
| Students, Medical | 1 | 2014 | 455 | 0.300 |
Why?
|
| Occupational Diseases | 1 | 2009 | 57 | 0.300 |
Why?
|
| Hematoma | 3 | 2023 | 109 | 0.290 |
Why?
|
| Follow-Up Studies | 16 | 2017 | 3927 | 0.290 |
Why?
|
| Sensitivity and Specificity | 9 | 2015 | 2039 | 0.290 |
Why?
|
| Clinical Competence | 1 | 2014 | 854 | 0.290 |
Why?
|
| Common Bile Duct | 1 | 2008 | 19 | 0.280 |
Why?
|
| Choledocholithiasis | 1 | 2008 | 14 | 0.280 |
Why?
|
| Vena Cava, Superior | 4 | 2023 | 60 | 0.280 |
Why?
|
| Diagnosis, Differential | 7 | 2012 | 1619 | 0.280 |
Why?
|
| Postoperative Hemorrhage | 1 | 2008 | 50 | 0.270 |
Why?
|
| Nephrectomy | 1 | 2010 | 297 | 0.270 |
Why?
|
| Lower Gastrointestinal Tract | 2 | 2004 | 9 | 0.270 |
Why?
|
| Brachial Artery | 2 | 2020 | 36 | 0.270 |
Why?
|
| Heart-Assist Devices | 1 | 2015 | 898 | 0.260 |
Why?
|
| Pipecolic Acids | 1 | 2006 | 14 | 0.250 |
Why?
|
| Equipment Failure | 6 | 2011 | 128 | 0.250 |
Why?
|
| Fluoroscopy | 8 | 2020 | 138 | 0.240 |
Why?
|
| Fistula | 2 | 2021 | 42 | 0.240 |
Why?
|
| Iliac Vein | 2 | 2011 | 32 | 0.240 |
Why?
|
| Drainage | 4 | 2009 | 172 | 0.240 |
Why?
|
| Antineoplastic Agents | 2 | 2011 | 2418 | 0.230 |
Why?
|
| Kidney Neoplasms | 1 | 2010 | 558 | 0.220 |
Why?
|
| Acute Disease | 4 | 2024 | 872 | 0.220 |
Why?
|
| Central Venous Catheters | 2 | 2015 | 22 | 0.220 |
Why?
|
| Nephrostomy, Percutaneous | 2 | 2004 | 30 | 0.220 |
Why?
|
| Proof of Concept Study | 1 | 2024 | 57 | 0.210 |
Why?
|
| Medicare | 3 | 2021 | 458 | 0.210 |
Why?
|
| Bile Ducts, Intrahepatic | 3 | 2022 | 68 | 0.210 |
Why?
|
| Pulmonary Circulation | 1 | 2024 | 92 | 0.210 |
Why?
|
| Multimodal Imaging | 1 | 2025 | 115 | 0.210 |
Why?
|
| Cholangiocarcinoma | 1 | 2024 | 80 | 0.210 |
Why?
|
| Jejunostomy | 1 | 2003 | 13 | 0.210 |
Why?
|
| Hepatectomy | 1 | 2024 | 178 | 0.200 |
Why?
|
| Portasystemic Shunt, Transjugular Intrahepatic | 3 | 2011 | 43 | 0.200 |
Why?
|
| Femoral Vein | 3 | 2005 | 42 | 0.200 |
Why?
|
| Equipment Design | 4 | 2015 | 427 | 0.200 |
Why?
|
| Dialysis | 1 | 2003 | 24 | 0.200 |
Why?
|
| Vascular Fistula | 1 | 2003 | 12 | 0.200 |
Why?
|
| Ischemia | 2 | 2024 | 256 | 0.190 |
Why?
|
| Radiation Dosage | 2 | 2020 | 236 | 0.190 |
Why?
|
| Workload | 2 | 2020 | 133 | 0.190 |
Why?
|
| Hemostasis, Endoscopic | 1 | 2002 | 16 | 0.190 |
Why?
|
| Venous Pressure | 1 | 2002 | 11 | 0.190 |
Why?
|
| Hypertension, Portal | 1 | 2022 | 47 | 0.190 |
Why?
|
| Klippel-Trenaunay-Weber Syndrome | 1 | 2002 | 4 | 0.180 |
Why?
|
| Chicago | 5 | 2019 | 1506 | 0.180 |
Why?
|
| Arteries | 1 | 2022 | 181 | 0.180 |
Why?
|
| Appendix | 1 | 2001 | 31 | 0.180 |
Why?
|
| Leg | 1 | 2002 | 143 | 0.170 |
Why?
|
| Referral and Consultation | 1 | 2004 | 386 | 0.170 |
Why?
|
| Head and Neck Neoplasms | 2 | 2021 | 1089 | 0.170 |
Why?
|
| United States | 8 | 2024 | 7768 | 0.170 |
Why?
|
| Hemorrhage | 2 | 2020 | 294 | 0.170 |
Why?
|
| Acetylcysteine | 1 | 2001 | 73 | 0.170 |
Why?
|
| Hospital Units | 1 | 2020 | 29 | 0.170 |
Why?
|
| Health Care Costs | 1 | 2022 | 255 | 0.160 |
Why?
|
| International Normalized Ratio | 1 | 2020 | 38 | 0.160 |
Why?
|
| Hospital Charges | 1 | 2020 | 32 | 0.160 |
Why?
|
| Platelet Count | 1 | 2020 | 97 | 0.160 |
Why?
|
| Ultrasonography, Interventional | 3 | 2009 | 125 | 0.160 |
Why?
|
| Appointments and Schedules | 1 | 2020 | 59 | 0.160 |
Why?
|
| Radiology Information Systems | 1 | 2020 | 78 | 0.160 |
Why?
|
| Cholestasis, Intrahepatic | 1 | 1999 | 14 | 0.160 |
Why?
|
| Celiac Artery | 1 | 2000 | 25 | 0.160 |
Why?
|
| Ligaments | 1 | 2000 | 34 | 0.160 |
Why?
|
| Diverticulum | 1 | 2000 | 45 | 0.160 |
Why?
|
| Blood Coagulation Disorders | 1 | 2020 | 67 | 0.150 |
Why?
|
| Radiopharmaceuticals | 1 | 2020 | 204 | 0.150 |
Why?
|
| Diaphragm | 1 | 2000 | 75 | 0.150 |
Why?
|
| Saphenous Vein | 1 | 1999 | 61 | 0.150 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2000 | 111 | 0.150 |
Why?
|
| Reproducibility of Results | 3 | 2015 | 2882 | 0.150 |
Why?
|
| Arm | 1 | 1999 | 100 | 0.150 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2003 | 3639 | 0.150 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2004 | 647 | 0.150 |
Why?
|
| Infant | 8 | 2013 | 3363 | 0.150 |
Why?
|
| Kidney Diseases | 1 | 2001 | 323 | 0.140 |
Why?
|
| Prosthesis Implantation | 1 | 2019 | 131 | 0.140 |
Why?
|
| Blood Flow Velocity | 2 | 2016 | 201 | 0.140 |
Why?
|
| Hemodynamics | 1 | 2002 | 775 | 0.140 |
Why?
|
| Colon | 1 | 2001 | 542 | 0.140 |
Why?
|
| Models, Cardiovascular | 2 | 2020 | 110 | 0.140 |
Why?
|
| Treatment Refusal | 1 | 1998 | 68 | 0.140 |
Why?
|
| Anastomosis, Surgical | 5 | 2005 | 284 | 0.140 |
Why?
|
| Child, Preschool | 12 | 2006 | 3974 | 0.140 |
Why?
|
| Suture Techniques | 2 | 2014 | 143 | 0.140 |
Why?
|
| Heparin Antagonists | 1 | 1997 | 3 | 0.140 |
Why?
|
| Colonoscopy | 1 | 2000 | 304 | 0.140 |
Why?
|
| Protamines | 1 | 1997 | 8 | 0.140 |
Why?
|
| Neck | 1 | 1998 | 99 | 0.130 |
Why?
|
| Hepatic Veins | 2 | 2011 | 26 | 0.130 |
Why?
|
| Drug Hypersensitivity | 1 | 1997 | 40 | 0.130 |
Why?
|
| Gadolinium DTPA | 1 | 1998 | 255 | 0.130 |
Why?
|
| Point-of-Care Systems | 1 | 1998 | 156 | 0.130 |
Why?
|
| Catheter-Related Infections | 2 | 2014 | 24 | 0.130 |
Why?
|
| Iliac Artery | 2 | 2011 | 42 | 0.130 |
Why?
|
| Betacoronavirus | 1 | 2020 | 284 | 0.130 |
Why?
|
| Cost-Benefit Analysis | 4 | 2012 | 501 | 0.130 |
Why?
|
| Child | 13 | 2006 | 7626 | 0.130 |
Why?
|
| Incidence | 3 | 2015 | 1715 | 0.120 |
Why?
|
| Brachiocephalic Trunk | 1 | 2016 | 14 | 0.120 |
Why?
|
| Stomach | 2 | 2011 | 115 | 0.120 |
Why?
|
| Magnetic Resonance Angiography | 1 | 1998 | 276 | 0.120 |
Why?
|
| Analgesics, Opioid | 1 | 2020 | 513 | 0.120 |
Why?
|
| Sutures | 2 | 2014 | 59 | 0.120 |
Why?
|
| Meningitis, Bacterial | 1 | 1995 | 14 | 0.110 |
Why?
|
| Computer Simulation | 3 | 2020 | 1158 | 0.110 |
Why?
|
| Prospective Studies | 7 | 2020 | 4671 | 0.110 |
Why?
|
| Actinomycosis | 1 | 1995 | 13 | 0.110 |
Why?
|
| Vascular Access Devices | 1 | 2014 | 6 | 0.110 |
Why?
|
| Arteriovenous Anastomosis | 1 | 2014 | 2 | 0.110 |
Why?
|
| Needs Assessment | 1 | 2015 | 171 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 2 | 2012 | 1096 | 0.110 |
Why?
|
| Punctures | 3 | 2005 | 29 | 0.100 |
Why?
|
| Colectomy | 1 | 2015 | 192 | 0.100 |
Why?
|
| Cholangiography | 3 | 2005 | 38 | 0.100 |
Why?
|
| Sampling Studies | 1 | 2013 | 76 | 0.100 |
Why?
|
| Reoperation | 2 | 2014 | 707 | 0.100 |
Why?
|
| Dilatation | 2 | 2006 | 48 | 0.100 |
Why?
|
| Injections, Subcutaneous | 1 | 2013 | 134 | 0.100 |
Why?
|
| Bacterial Infections | 1 | 2014 | 185 | 0.100 |
Why?
|
| Treatment Failure | 1 | 2013 | 297 | 0.090 |
Why?
|
| Mesenteric Artery, Superior | 2 | 2004 | 18 | 0.090 |
Why?
|
| Infusions, Intravenous | 2 | 2006 | 423 | 0.090 |
Why?
|
| Feasibility Studies | 4 | 2011 | 819 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1997 | 595 | 0.090 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2024 | 883 | 0.090 |
Why?
|
| Decision Trees | 1 | 2012 | 63 | 0.090 |
Why?
|
| Aneurysm, Ruptured | 1 | 2012 | 62 | 0.090 |
Why?
|
| Thoracic Diseases | 1 | 2012 | 28 | 0.090 |
Why?
|
| Models, Economic | 1 | 2012 | 62 | 0.090 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2011 | 41 | 0.090 |
Why?
|
| Hawaii | 4 | 1998 | 26 | 0.090 |
Why?
|
| Cost Savings | 1 | 2012 | 71 | 0.090 |
Why?
|
| Regional Blood Flow | 2 | 2020 | 197 | 0.090 |
Why?
|
| Cholecystography | 1 | 2011 | 6 | 0.090 |
Why?
|
| Uterine Artery Embolization | 1 | 2011 | 5 | 0.090 |
Why?
|
| Monte Carlo Method | 1 | 2012 | 191 | 0.090 |
Why?
|
| Cholecystostomy | 1 | 2011 | 5 | 0.090 |
Why?
|
| Survival Rate | 1 | 2015 | 1985 | 0.090 |
Why?
|
| Yttrium Radioisotopes | 2 | 2021 | 48 | 0.090 |
Why?
|
| Embolic Protection Devices | 1 | 2011 | 9 | 0.090 |
Why?
|
| Urokinase-Type Plasminogen Activator | 3 | 2005 | 51 | 0.090 |
Why?
|
| Aortography | 1 | 2011 | 67 | 0.090 |
Why?
|
| Needles | 3 | 2001 | 42 | 0.080 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2011 | 43 | 0.080 |
Why?
|
| Duodenum | 1 | 2011 | 112 | 0.080 |
Why?
|
| Renal Veins | 2 | 2017 | 27 | 0.080 |
Why?
|
| Pacemaker, Artificial | 1 | 2011 | 105 | 0.080 |
Why?
|
| Decision Support Techniques | 1 | 2012 | 186 | 0.080 |
Why?
|
| Radiotherapy | 1 | 2012 | 328 | 0.080 |
Why?
|
| Body Fluids | 1 | 2009 | 35 | 0.080 |
Why?
|
| Intubation, Gastrointestinal | 2 | 2001 | 31 | 0.080 |
Why?
|
| Collateral Circulation | 2 | 2001 | 40 | 0.080 |
Why?
|
| Chi-Square Distribution | 2 | 2024 | 363 | 0.080 |
Why?
|
| Retroperitoneal Space | 1 | 2009 | 42 | 0.080 |
Why?
|
| Pancreas | 1 | 2011 | 264 | 0.080 |
Why?
|
| Enteral Nutrition | 2 | 2021 | 105 | 0.070 |
Why?
|
| Periodicals as Topic | 1 | 2011 | 171 | 0.070 |
Why?
|
| Communicable Diseases | 1 | 2009 | 69 | 0.070 |
Why?
|
| Medical Oncology | 1 | 2012 | 408 | 0.070 |
Why?
|
| Syndrome | 1 | 2009 | 453 | 0.070 |
Why?
|
| Polytetrafluoroethylene | 2 | 1999 | 74 | 0.070 |
Why?
|
| Venous Thromboembolism | 1 | 2011 | 171 | 0.070 |
Why?
|
| Travel | 1 | 1988 | 72 | 0.070 |
Why?
|
| Bariatric Surgery | 1 | 2011 | 207 | 0.070 |
Why?
|
| Scabies | 1 | 1987 | 2 | 0.070 |
Why?
|
| Obesity, Morbid | 1 | 2011 | 247 | 0.070 |
Why?
|
| Illinois | 2 | 2014 | 531 | 0.070 |
Why?
|
| Heart | 1 | 2011 | 591 | 0.070 |
Why?
|
| Neoplasms | 2 | 2002 | 3248 | 0.070 |
Why?
|
| Stress, Mechanical | 2 | 2020 | 261 | 0.070 |
Why?
|
| Image Enhancement | 1 | 2010 | 565 | 0.070 |
Why?
|
| Leiomyoma | 1 | 2011 | 211 | 0.070 |
Why?
|
| Budd-Chiari Syndrome | 1 | 2006 | 9 | 0.060 |
Why?
|
| Severity of Illness Index | 3 | 2020 | 1981 | 0.060 |
Why?
|
| Hemofiltration | 1 | 2006 | 11 | 0.060 |
Why?
|
| Skin Diseases | 1 | 1988 | 176 | 0.060 |
Why?
|
| Uterine Neoplasms | 1 | 2011 | 278 | 0.060 |
Why?
|
| Life Tables | 3 | 2005 | 47 | 0.060 |
Why?
|
| Herpes Zoster | 1 | 1987 | 80 | 0.060 |
Why?
|
| Ultrasonography, Doppler | 2 | 1997 | 83 | 0.060 |
Why?
|
| Arginine | 1 | 2006 | 144 | 0.060 |
Why?
|
| Splenorenal Shunt, Surgical | 1 | 2005 | 3 | 0.060 |
Why?
|
| Extremities | 1 | 2006 | 179 | 0.060 |
Why?
|
| Biliary Tract Diseases | 1 | 2005 | 37 | 0.060 |
Why?
|
| Retreatment | 2 | 2002 | 106 | 0.050 |
Why?
|
| Liver Cirrhosis | 1 | 2006 | 276 | 0.050 |
Why?
|
| Sulfonamides | 1 | 2006 | 337 | 0.050 |
Why?
|
| Duodenal Diseases | 1 | 2004 | 25 | 0.050 |
Why?
|
| Hydronephrosis | 1 | 2004 | 30 | 0.050 |
Why?
|
| Urinary Catheterization | 1 | 2004 | 40 | 0.050 |
Why?
|
| Phlebotomy | 2 | 2001 | 23 | 0.050 |
Why?
|
| SEER Program | 1 | 2024 | 235 | 0.050 |
Why?
|
| Longitudinal Studies | 2 | 2014 | 1176 | 0.050 |
Why?
|
| Technetium | 1 | 2003 | 29 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2010 | 1471 | 0.050 |
Why?
|
| Iatrogenic Disease | 2 | 2002 | 72 | 0.050 |
Why?
|
| Tumor Burden | 1 | 2024 | 322 | 0.050 |
Why?
|
| Ureteral Obstruction | 1 | 2004 | 70 | 0.050 |
Why?
|
| Pneumothorax | 2 | 2000 | 52 | 0.050 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 1 | 2003 | 10 | 0.050 |
Why?
|
| Splenic Artery | 1 | 2022 | 10 | 0.050 |
Why?
|
| Boston | 1 | 2022 | 39 | 0.050 |
Why?
|
| Vasopressins | 1 | 2002 | 50 | 0.050 |
Why?
|
| New York | 1 | 2022 | 75 | 0.050 |
Why?
|
| Gastrointestinal Diseases | 1 | 2003 | 154 | 0.050 |
Why?
|
| Erythrocytes | 1 | 2003 | 254 | 0.050 |
Why?
|
| Bile Ducts | 1 | 2002 | 61 | 0.050 |
Why?
|
| Intubation | 2 | 1999 | 23 | 0.050 |
Why?
|
| Microwaves | 1 | 2022 | 32 | 0.050 |
Why?
|
| Arteriosclerosis | 1 | 2002 | 112 | 0.040 |
Why?
|
| Injections, Intravenous | 2 | 1999 | 238 | 0.040 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2001 | 25 | 0.040 |
Why?
|
| Tourniquets | 1 | 2000 | 11 | 0.040 |
Why?
|
| Bile | 1 | 2001 | 61 | 0.040 |
Why?
|
| Lower Extremity | 1 | 2021 | 98 | 0.040 |
Why?
|
| Administration, Rectal | 1 | 2000 | 13 | 0.040 |
Why?
|
| Hemostasis, Surgical | 1 | 2000 | 25 | 0.040 |
Why?
|
| Intraoperative Complications | 1 | 2002 | 197 | 0.040 |
Why?
|
| Physician's Role | 1 | 2002 | 186 | 0.040 |
Why?
|
| Neointima | 1 | 2020 | 14 | 0.040 |
Why?
|
| Age Factors | 3 | 2014 | 1963 | 0.040 |
Why?
|
| Efficiency, Organizational | 1 | 2020 | 55 | 0.040 |
Why?
|
| Mechanical Thrombolysis | 1 | 2020 | 18 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2020 | 98 | 0.040 |
Why?
|
| Heparin | 2 | 1999 | 186 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2003 | 1546 | 0.040 |
Why?
|
| Hyperplasia | 1 | 2020 | 149 | 0.040 |
Why?
|
| Workflow | 1 | 2020 | 80 | 0.040 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 2000 | 20 | 0.040 |
Why?
|
| Metformin | 1 | 2001 | 125 | 0.040 |
Why?
|
| Biopsy, Needle | 1 | 2020 | 231 | 0.040 |
Why?
|
| Parenteral Nutrition, Total | 1 | 1999 | 41 | 0.040 |
Why?
|
| Image-Guided Biopsy | 1 | 2020 | 82 | 0.040 |
Why?
|
| Hypotension | 1 | 2020 | 76 | 0.040 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2019 | 38 | 0.040 |
Why?
|
| Radiation Exposure | 1 | 2019 | 25 | 0.040 |
Why?
|
| Thigh | 1 | 1999 | 41 | 0.040 |
Why?
|
| Plasminogen Activators | 1 | 1999 | 11 | 0.040 |
Why?
|
| Mortality | 1 | 2020 | 154 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2012 | 2463 | 0.040 |
Why?
|
| Diatrizoate Meglumine | 1 | 1998 | 18 | 0.040 |
Why?
|
| Jejunum | 1 | 1999 | 80 | 0.040 |
Why?
|
| Hospitals, Community | 1 | 1998 | 35 | 0.040 |
Why?
|
| Anesthesia, General | 1 | 2019 | 127 | 0.040 |
Why?
|
| Hemostatic Techniques | 1 | 1998 | 19 | 0.040 |
Why?
|
| Suction | 1 | 1998 | 38 | 0.040 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2020 | 167 | 0.030 |
Why?
|
| Insulin, Isophane | 1 | 1997 | 2 | 0.030 |
Why?
|
| Diabetic Nephropathies | 2 | 2009 | 90 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2022 | 1010 | 0.030 |
Why?
|
| Urinary Diversion | 1 | 1998 | 44 | 0.030 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 1997 | 15 | 0.030 |
Why?
|
| Carotid Arteries | 1 | 1998 | 136 | 0.030 |
Why?
|
| Drug Interactions | 1 | 1997 | 245 | 0.030 |
Why?
|
| Conscious Sedation | 1 | 1997 | 78 | 0.030 |
Why?
|
| Ureter | 1 | 1998 | 96 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 1998 | 873 | 0.030 |
Why?
|
| Thyroid Gland | 1 | 1998 | 281 | 0.030 |
Why?
|
| Ambulatory Care | 1 | 1997 | 198 | 0.030 |
Why?
|
| Ethics, Medical | 1 | 1998 | 312 | 0.030 |
Why?
|
| Sex Factors | 2 | 2014 | 1133 | 0.030 |
Why?
|
| Esophageal and Gastric Varices | 2 | 2006 | 36 | 0.030 |
Why?
|
| Methods | 1 | 1995 | 148 | 0.030 |
Why?
|
| Cavernous Sinus | 1 | 1995 | 15 | 0.030 |
Why?
|
| Hypoglycemic Agents | 1 | 1997 | 376 | 0.030 |
Why?
|
| Brain Edema | 1 | 1995 | 61 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1998 | 1973 | 0.030 |
Why?
|
| Blood Viscosity | 1 | 2014 | 15 | 0.030 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2014 | 38 | 0.030 |
Why?
|
| Patient-Specific Modeling | 1 | 2014 | 24 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2014 | 175 | 0.030 |
Why?
|
| Age Distribution | 1 | 2014 | 209 | 0.030 |
Why?
|
| Kidney | 1 | 1998 | 1137 | 0.020 |
Why?
|
| Internship and Residency | 1 | 2001 | 1134 | 0.020 |
Why?
|
| Mediastinal Diseases | 1 | 2012 | 22 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 1010 | 0.020 |
Why?
|
| Delphi Technique | 1 | 2012 | 136 | 0.020 |
Why?
|
| Contraceptives, Oral | 1 | 2011 | 49 | 0.020 |
Why?
|
| Contraindications | 1 | 2011 | 70 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2006 | 2614 | 0.020 |
Why?
|
| Ultrasonic Therapy | 1 | 2011 | 43 | 0.020 |
Why?
|
| Comorbidity | 1 | 2014 | 1011 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2014 | 926 | 0.020 |
Why?
|
| APACHE | 1 | 2009 | 24 | 0.020 |
Why?
|
| Hysterectomy | 1 | 2011 | 168 | 0.020 |
Why?
|
| Uterus | 1 | 2011 | 228 | 0.020 |
Why?
|
| Linear Models | 1 | 2009 | 438 | 0.020 |
Why?
|
| Biopsy | 1 | 2012 | 1220 | 0.020 |
Why?
|
| Alloys | 1 | 2007 | 10 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2011 | 815 | 0.020 |
Why?
|
| Outpatients | 1 | 2008 | 105 | 0.020 |
Why?
|
| Equipment Safety | 1 | 2007 | 32 | 0.020 |
Why?
|
| ROC Curve | 1 | 2009 | 797 | 0.020 |
Why?
|
| Prosthesis-Related Infections | 1 | 2007 | 60 | 0.020 |
Why?
|
| Bacteremia | 1 | 2007 | 108 | 0.010 |
Why?
|
| Femur | 1 | 2005 | 108 | 0.010 |
Why?
|
| Brain | 1 | 1995 | 2482 | 0.010 |
Why?
|
| Laparoscopy | 1 | 2011 | 784 | 0.010 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2005 | 181 | 0.010 |
Why?
|
| Staphylococcal Infections | 1 | 2007 | 289 | 0.010 |
Why?
|
| Digestive System | 1 | 2003 | 42 | 0.010 |
Why?
|
| Research Design | 1 | 2007 | 631 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 2003 | 217 | 0.010 |
Why?
|
| Cadaver | 1 | 2002 | 204 | 0.010 |
Why?
|
| Probability | 1 | 2003 | 365 | 0.010 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 2002 | 52 | 0.010 |
Why?
|
| Reference Values | 1 | 2003 | 674 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2007 | 847 | 0.010 |
Why?
|
| Observer Variation | 1 | 2003 | 626 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2003 | 522 | 0.010 |
Why?
|
| Living Donors | 1 | 2002 | 348 | 0.010 |
Why?
|
| Graft Survival | 1 | 2002 | 942 | 0.010 |
Why?
|
| Ureteral Diseases | 1 | 1998 | 14 | 0.010 |
Why?
|
| Intestinal Fistula | 1 | 1998 | 31 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2003 | 1957 | 0.010 |
Why?
|
| Kidney Pelvis | 1 | 1998 | 52 | 0.010 |
Why?
|
| Cause of Death | 1 | 1999 | 278 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 1998 | 159 | 0.010 |
Why?
|
| Registries | 1 | 2003 | 986 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 1998 | 157 | 0.010 |
Why?
|
| Cystectomy | 1 | 1998 | 114 | 0.010 |
Why?
|
| Radiographic Image Enhancement | 1 | 1999 | 467 | 0.010 |
Why?
|
| Tissue Donors | 1 | 1996 | 542 | 0.010 |
Why?
|